BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cho JH. Inflammatory bowel disease: Genetic and epidemiologic considerations. World J Gastroenterol 2008; 14(3): 338-347 [PMID: 18200657 DOI: 10.3748/wjg.14.338]
URL: https://www.wjgnet.com/1007-9327/full/v14/i3/338.htm
Number Citing Articles
1
K. Herrlinger, B. Wittig, E.F. Stange. Chronisch entzündliche DarmerkrankungenDer Internist 2009; 50(10): 1229 doi: 10.1007/s00108-009-2485-9
2
O J Broom, B Widjaya, J Troelsen, J Olsen, O H Nielsen. Mitogen activated protein kinases: a role in inflammatory bowel disease?Clinical and Experimental Immunology 2009; 158(3): 272 doi: 10.1111/j.1365-2249.2009.04033.x
3
Gwan Gyu Song, Young Ho Lee. The Polymorphisms K469E and G261R of Intercellular Adhesion Molecule-1 and Susceptibility to Inflammatory Bowel Disease: A Meta-AnalysisImmunological Investigations 2015; 44(4): 361 doi: 10.3109/08820139.2015.1010685
4
Dago Dougba Noel, Pinelli Marinella, Giacomelli Mauro, Serena Ilaria Tripodi, Alessia Pin, Arrigo Serena, Bramuzzo Matteo, Fuoti Maurizio Giuseppe, Alvisi Patrizia, Calza Stefano, Alberto Tommasini, Badolato Raffaele. Genetic Variants Assessing Crohn’s Disease Pattern in Pediatric Inflammatory Bowel Disease Patients by a Clinical Exome SurveyBioinformatics and Biology Insights 2021; 15: 117793222110552 doi: 10.1177/11779322211055285
5
Antje Timmer, Lloyd R. Sutherland. Handbook of Epidemiology2014; : 2355 doi: 10.1007/978-0-387-09834-0_49
6
Shahram Nemati, Shahram Teimourian. An Overview of Inflammatory Bowel Disease: General Consideration and Genetic Screening Approach in Diagnosis of Early Onset SubsetsMiddle East Journal of Digestive Diseases 2017; 9(2): 69 doi: 10.15171/mejdd.2017.54
7
Changmei Hu, Liang Lv, Deliang Liu, Jirong Huo. Treatment of Crohn’s disease complicated with myelodysplastic syndrome via allogeneic hematopoietic stem cell transplantation: case report and literature reviewClinical Journal of Gastroenterology 2014; 7(4): 299 doi: 10.1007/s12328-014-0496-0
8
Akira Meguro, Mami Ishihara, Martin Petrek, Ken Yamamoto, Masaki Takeuchi, Frantisek Mrazek, Vitezslav Kolek, Alzbeta Benicka, Takahiro Yamane, Etsuko Shibuya, Atsushi Yoshino, Akiko Isomoto, Masao Ota, Keisuke Yatsu, Noriharu Shijubo, Sonoko Nagai, Etsuro Yamaguchi, Tetsuo Yamaguchi, Kenichi Namba, Toshikatsu Kaburaki, Hiroshi Takase, Shin-ichiro Morimoto, Junko Hori, Keiko Kono, Hiroshi Goto, Takafumi Suda, Soichiro Ikushima, Yasutaka Ando, Shinobu Takenaka, Masaru Takeuchi, Takenosuke Yuasa, Katsunori Sugisaki, Nobuyuki Ohguro, Miki Hiraoka, Nobuyoshi Kitaichi, Yukihiko Sugiyama, Nobuyuki Horita, Yuri Asukata, Tatsukata Kawagoe, Ikuko Kimura, Mizuho Ishido, Hidetoshi Inoko, Manabu Mochizuki, Shigeaki Ohno, Seiamak Bahram, Elaine F. Remmers, Daniel L. Kastner, Nobuhisa Mizuki. Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosisCommunications Biology 2020; 3(1) doi: 10.1038/s42003-020-01185-9
9
J Grundström, L Linton, S Thunberg, H Forsslund, I Janczewska, R Befrits, M van Hage, G Gafvelin, M Eberhardson. Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel diseaseClinical and Experimental Immunology 2012; 169(2): 137 doi: 10.1111/j.1365-2249.2012.04600.x
10
Nezha Senhaji, Kevin Kojok, Youssef Darif, Christophe Fadainia, Younes Zaid. The Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An UpdateFrontiers in Immunology 2015; 6 doi: 10.3389/fimmu.2015.00529
11
Yunhai Li, Ping Chen, Jiazheng Sun, Jing Huang, Hongtao Tie, Liangliang Li, Hongzhong Li, Guosheng Ren. Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel diseaseScientific Reports 2016; 6(1) doi: 10.1038/srep33550
12
Stephen M. Collins, Kenneth Croitoru. Inflammatory Bowel Disease2010; : 182 doi: 10.1002/9781444318418.ch13
13
Michael A. Lynes, Juan Hidalgo, Yasmina Manso, Lindsey Devisscher, Debby Laukens, David A. Lawrence. Metallothionein and stress combine to affect multiple organ systemsCell Stress and Chaperones 2014; 19(5): 605 doi: 10.1007/s12192-014-0501-z
14
Sofia Roth, Marianne R. Spalinger, Isabelle Müller, Silvia Lang, Gerhard Rogler, Michael Scharl. Bilberry-Derived Anthocyanins Prevent IFN-γ-Induced Pro-Inflammatory Signalling and Cytokine Secretion in Human THP-1 Monocytic CellsDigestion 2014; 90(3): 179 doi: 10.1159/000366055
15
Ulrike Strauch, Jürgen Schölmerich. Emerging drugs to treat Crohn's diseaseExpert Opinion on Emerging Drugs 2010; 15(2): 309 doi: 10.1517/14728214.2010.480972
16
Bárbara F. Cordeiro, Luisa Lemos, Emiliano R. Oliveira, Sara H. Silva, Bruna Savassi, Alessandra Figueiroa, Ana Maria C. Faria, Enio Ferreira, Erick A. Esmerino, Ramon S. Rocha, Mônica Q. Freitas, Marcia C. Silva, Adriano G. Cruz, Fillipe Luiz R. do Carmo, Vasco Azevedo. Prato cheese containing Lactobacillus casei 01 fails to prevent dextran sodium sulphate-induced colitisInternational Dairy Journal 2019; 99: 104551 doi: 10.1016/j.idairyj.2019.104551
17
Zi-Teng Zhang, Xiu-Juan Ma, Ying Zong, Xiu-Ming Du, Jin-Hua Hu, Guo-Cai Lu. Is the CARD8 rs2043211 polymorphism associated with susceptibility to Crohn’s disease? A meta-analysisAutoimmunity 2015; 48(8): 524 doi: 10.3109/08916934.2015.1045581
18
Luiz Eduardo Baggio Savio, Simon C. Robson, Maria Serena Longhi. Ectonucleotidase Modulation of Lymphocyte Function in Gut and LiverFrontiers in Cell and Developmental Biology 2021; 8 doi: 10.3389/fcell.2020.621760
19
Klaus R. Herrlinger, Eduard F. Stange. Twenty‐five years of biologicals in IBD: What´s all the hype about?Journal of Internal Medicine 2021; 290(4): 806 doi: 10.1111/joim.13345
20
Jeroen Hol, Johan C. de Jongste, Edward E. Nieuwenhuis. Quoting a landmark paper on the beneficial effects of probioticsJournal of Allergy and Clinical Immunology 2009; 124(6): 1354 doi: 10.1016/j.jaci.2009.07.047
21
Doha Anka Idrissi, Nezha Senhaji, Asmae Aouiss, Loubna Khalki, Youssef Tijani, Nabil Zaid, Fatima Zahra Marhoume, Abdallah Naya, Mounia Oudghiri, Mostafa Kabine, Younes Zaid. IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn’s disease and new therapeutic targetsArchives of Pharmacal Research 2021; 44(1): 117 doi: 10.1007/s12272-020-01296-1
22
Eduard F. Stange. Current and future aspects of IBD research and treatment: The 2022 perspectiveFrontiers in Gastroenterology 2022; 1 doi: 10.3389/fgstr.2022.914371
23
Young Ho Lee, Jae-Hoon Kim, Young Ho Seo, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song. CTLA-4 polymorphisms and susceptibility to inflammatory bowel disease: A meta-analysisHuman Immunology 2014; 75(5): 414 doi: 10.1016/j.humimm.2014.02.020
24
Hye‐Youn Kim, Hyeok Yi Kwon, Huyen Trang Ha Thi, Ho Jae Lee, Gwang Il Kim, Ki‐Baek Hahm, Suntaek Hong. MicroRNA‐132 and microRNA‐223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel diseaseJournal of Gastroenterology and Hepatology 2016; 31(10): 1727 doi: 10.1111/jgh.13321
25
Wang-Dong Xu, Qi-Bing Xie, Yi Zhao, Yi Liu. Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn’s disease: A meta-analysisScientific Reports 2015; 5(1) doi: 10.1038/srep18584
26
Roger Yazbeck, Gordon S. Howarth, Catherine A. Abbott. Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?Cytokine & Growth Factor Reviews 2009; 20(2): 175 doi: 10.1016/j.cytogfr.2009.02.008
27
Bernard Swynghedauw. Une introduction à la médecine évolutionniste L’évolution biologique, grande absente de l’enseignement médicalBulletin de l'Académie Nationale de Médecine 2009; 193(5): 1147 doi: 10.1016/S0001-4079(19)32503-8
28
Anna L. Peters, Laura L. Stunz, Gail A. Bishop. CD40 and autoimmunity: The dark side of a great activatorSeminars in Immunology 2009; 21(5): 293 doi: 10.1016/j.smim.2009.05.012
29
Xuhang Li, Laurie Conklin, Philip Alex. New serological biomarkers of inflammatory bowel diseaseWorld Journal of Gastroenterology 2008; 14(33): 5115-5124 doi: 10.3748/wjg.14.5115
30
Gwan Gyu Song, Young Ho Seo, Jae-Hoon Kim, Sung Jae Choi, Jong Dae Ji, Young Ho Lee. Association between TNF-α (-308 A/G, -238 A/G, -857 C/T) polymorphisms and responsiveness to TNF-α blockers in spondyloarthropathy, psoriasis and Crohn's disease: a meta-analysisPharmacogenomics 2015; 16(12): 1427 doi: 10.2217/pgs.15.90
31
Jie Wu, Yan Cheng, Rong Zhang, Hao Shen, Li Ma, Jun Yang, Yanting Zhang, Jun Zhang. Evaluating the Association of Common Variants of the SLC44A4 Gene with Ulcerative Colitis Susceptibility in the Han Chinese PopulationGenetic Testing and Molecular Biomarkers 2017; 21(9): 555 doi: 10.1089/gtmb.2017.0010
32
Agata Anna Cisek, Edyta Szymańska, Aldona Wierzbicka-Rucińska, Tamara Aleksandrzak-Piekarczyk, Bożena Cukrowska. Methanogenic Archaea in the Pediatric Inflammatory Bowel Disease in Relation to Disease Type and ActivityInternational Journal of Molecular Sciences 2024; 25(1): 673 doi: 10.3390/ijms25010673
33
Ling-Long Peng, Ying Wang, Feng-Ling Zhu, Wang-Dong Xu, Xue-Lei Ji, Jing Ni. IL-23R mutation is associated with ulcerative colitis: A systemic review and meta-analysisOncotarget 2017; 8(3): 4849 doi: 10.18632/oncotarget.13607
34
Gabriel D. Dakubo. Cancer Biomarkers in Body Fluids2019; : 273 doi: 10.1007/978-3-030-24725-6_14
35
Daniel C Baumgart. What’s new in inflammatory bowel disease in 2008?World Journal of Gastroenterology 2008; 14(3): 329-330 doi: 10.3748/wjg.14.329
36
Hong-xin Zhang, Zheng-ting Wang, Xiong-xiong Lu, Yan-gui Wang, Jie Zhong, Jie Liu. NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn’s disease (CD), in Chinese Han populationInflammation Research 2014; 63(12): 979 doi: 10.1007/s00011-014-0774-9
37
Sarah R. Glick, Ryan S. Carvalho. Inflammatory Bowel DiseasePediatrics In Review 2011; 32(1): 14 doi: 10.1542/pir.32.1.14
38
Sarah R. Glick, Ryan S. Carvalho. Inflammatory Bowel DiseasePediatrics In Review 2011; 32(1): 14 doi: 10.1542/pir.32.1.14
39
Young Ho Lee, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song. Associations between functional FCGR2A R131H and FCGR3A F158V polymorphisms and responsiveness to TNF blockers in spondyloarthropathy, psoriasis and Crohn's disease: a meta-analysisPharmacogenomics 2016; 17(13): 1465 doi: 10.2217/pgs.16.27